GSK (GSK) News Today GBX 1,511.50 -38.00 (-2.45%) As of 12:39 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesSustainabilityBuy This Stock Why is GSK Down Today?GSK plc (GSK) shares moved higher today as investors digest a string of regulatory advances, positive clinical data and an analyst upgrade that bolster the company’s vaccine and oncology outlook. European Medicines Agency accepts RSV vaccine Arexvy for regulatory review GSK files with EU regulator to expand approved use of its RSV vaccine NICE recommends the Blenrep combination for treatment of multiple myeloma Consensus “Moderate Buy” rating from six brokerages covering the stock New progression-free survival data strengthen Blenrep’s case for a US return Shigella vaccine candidate licensed/offloaded to Bharat Biotech ahead of Phase 3, with GSK supporting fundraising Technical indicator: stock has moved above its 200-day moving average, triggering sell-signal alerts Overall, regulatory and clinical milestones underpin GSK’s growth narrative, though short-term technical signals may encourage profit-taking.Posted 1h agoAI Generated. May Contain Errors. GSK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period GSK's RSV drug Arexvy accepted for regulatory review in EuropeJune 13 at 8:39 AM | lse.co.ukGSK applies to EU regulator for expanded use of RSV vaccineJune 13 at 8:39 AM | msn.comGSK plc (LON:GSK) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of GSK plc (LON:GSK - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the cJune 13 at 2:59 AM | marketbeat.comBharat Biotech in-licences GSK's Shigella vaccine candidateJune 12 at 4:35 PM | msn.comGSK (LON:GSK) Share Price Passes Above 200 Day Moving Average - Time to Sell?GSK (LON:GSK) Stock Passes Above 200-Day Moving Average - Here's What HappenedJune 12 at 3:12 AM | marketbeat.comAstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer share prices: Why are vaccine stocks down?June 10 at 5:33 PM | msn.comGSK climbs Thursday, outperforms marketJune 5, 2025 | marketwatch.comGSK (LON:GSK) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?GSK (LON:GSK) Shares Cross Above 200 Day Moving Average - Here's What HappenedJune 4, 2025 | marketbeat.comASCO 2025: GSK’s Jemperli fails to show OS benefit in 1L advanced ovarian cancerJune 3, 2025 | finance.yahoo.comGSK ADR Getting Closer To Key Technical BenchmarkJune 2, 2025 | msn.comIs the GSK share price finally getting its act together?June 2, 2025 | msn.comPharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline UpdatesMay 30, 2025 | msn.comGSK CEO Says Drugmaker Can Navigate Potential New U.S. TariffsMay 28, 2025 | wsj.comGSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s ThrilledMay 28, 2025 | msn.comGSK, Spero stop UTI drug trial after early successMay 28, 2025 | msn.comGSK ends cUTI trial early as Spero joint product meets efficacy goalMay 28, 2025 | lse.co.ukGSK Stops Antibiotic Trial Early After Seeing Positive ResultsMay 28, 2025 | bloomberg.comSpero surges as GSK-partnered UTI candidate succeeds in late-stage trialMay 28, 2025 | seekingalpha.comGSK (LON:GSK) Stock Passes Above 200-Day Moving Average - Should You Sell?GSK (LON:GSK) Stock Price Crosses Above 200-Day Moving Average - Here's What HappenedMay 28, 2025 | marketbeat.comGSK makes new drug submission for depemokimab in CanadaMay 27, 2025 | finance.yahoo.comGSK shares break six-session winning streakMay 24, 2025 | msn.comGSK's asthma drug wins FDA approval to treat 'smoker's lung'May 23, 2025 | msn.comUS Approves GSK Lung Disease Drug, Fueling Sanofi RivalryMay 23, 2025 | msn.comGSK plc (LON:GSK) Receives Average Rating of "Moderate Buy" from BrokeragesGSK plc (LON:GSK - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. TheMay 21, 2025 | marketbeat.comJapan approves GSK’s Blenrep combinations for multiple myeloma treatmentMay 19, 2025 | in.investing.comGSK to buy liver disease drug for up to $2 billionMay 14, 2025 | msn.comGSK plc (LON:GSK) Insider Julie Brown Acquires 10 SharesMay 14, 2025 | insidertrades.comWho’s Andrew Witty, the CEO who just stepped down at UnitedHealth?May 13, 2025 | msn.comIs GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?May 13, 2025 | msn.comGSK and Lifetime® launch original movie to raise awareness about the impact of meningitisMay 9, 2025 | finance.yahoo.comGSK Continues Share Buyback Program with Latest PurchaseMay 9, 2025 | msn.comGSK met main goal in liver disease treatment trialMay 9, 2025 | msn.comGSK plc (LON:GSK) Insider Emma Walmsley Sells 5,473 SharesMay 9, 2025 | insidertrades.comWhat’s going on with the GSK share price now?May 6, 2025 | msn.comGSK (LON:GSK) Given Buy Rating at Shore CapitalShore Capital restated a "buy" rating on shares of GSK in a research note on Wednesday.May 2, 2025 | marketbeat.comCould a new malaria jab really finish off the disease? Researchers at GSK have high hopesMay 2, 2025 | yahoo.comGSK insists it's 'well positioned' as Trump's pharma tariffs loomMay 1, 2025 | msn.comGSK’s Zejula reduces risk of progression and death in mesothelioma studyApril 30, 2025 | finance.yahoo.comGSK Sales, Profit Rise on Boost from HIV, Cancer DrugsApril 30, 2025 | msn.comFTSE 100 Live 30 April: Barclays and GSK update on tariffs, index on best run for eight yearsApril 30, 2025 | msn.comGSK Sales, Profit Rise on Boost from Cancer DrugsApril 30, 2025 | msn.comGSK Turnover, Net Profit Expected to Rise; Weaker Vaccine Performance in Focus -- Earnings PreviewApril 28, 2025 | marketwatch.comGSK plc (GSK)April 26, 2025 | finance.yahoo.comIs GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now?April 26, 2025 | msn.comGSK plc (LON:GSK) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of GSK plc (LON:GSK - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy ratApril 26, 2025 | marketbeat.comStocks Generating Improved Relative Strength: GSK ADRApril 22, 2025 | msn.comAlector concludes enrolment in Phase II trial of Alzheimer’s treatmentApril 21, 2025 | msn.comUK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatmentApril 21, 2025 | msn.comPharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?April 17, 2025 | msn.comGSK ‘s meningococcal vaccine receives positive recommendation in the U.S.April 17, 2025 | markets.businessinsider.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.200.88▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼65▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today ITH News Today HCM News Today GRI News Today INDV News Today BMY News Today OGN News Today GPH News Today IGC News Today AURA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
